IperionX (NASDAQ:IPX) Shares Down 7.5% – Time to Sell?

IperionX Limited Sponsored ADR (NASDAQ:IPX)’s share price was down 7.5% on Wednesday. The company traded as low as $15.64 and last traded at $15.7410. Approximately 153,723 shares were traded during mid-day trading, a decline of 44% from the average session volume of 273,032 shares. The stock had previously closed at $17.01.

Analyst Upgrades and Downgrades

Several research firms have issued reports on IPX. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research report on Friday, July 17th. B. Riley Financial decreased their price objective on IperionX from $52.00 to $34.00 and set a “buy” rating on the stock in a research note on Wednesday, September 30th. Jefferies Financial Group began coverage on IperionX in a report on Wednesday, September 2nd. They set a “buy” rating and a $26.00 price objective on the stock. Finally, Roth Capital set a $53.00 target price on IperionX in a research note on Wednesday, August 5th. Six analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $42.00.

IperionX Price Performance

The company has a 50 day moving average of $21.08 and a 200-day moving average of $27.50. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.95 and a current ratio of 3.24.

IperionX (NASDAQ:IPX) last announced its earnings results on Thursday, July 30th. The company reported ($0.50) earnings per share for the quarter. Equities research analysts anticipate that IperionX Limited Sponsored ADR will post -0.13 EPS for the current year.

Insider Activity at IperionX

In related news, CEO Anastasios Arima bought 138,720 shares of the stock in a transaction that occurred on Friday, July 10th. The shares were acquired at an average cost of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer directly owned 12,455,502 shares of the company’s stock, valued at $44,590,697.16. This trade represents a 1.13% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Chairman Todd Hannigan bought 300,000 shares of the company’s stock in a transaction on Monday, July 13th. The shares were bought at an average price of $3.59 per share, with a total value of $1,077,000.00. Following the completion of the transaction, the chairman owned 26,633,334 shares of the company’s stock, valued at $95,613,669.06. The trade was a 1.14% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders purchased 663,720 shares of company stock worth $2,379,118.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC lifted its holdings in shares of IperionX by 40.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after acquiring an additional 483 shares during the last quarter. Connective Capital Management LLC bought a new position in shares of IperionX during the 2nd quarter valued at $160,000. XY Capital Ltd bought a new position in shares of IperionX during the 4th quarter valued at $290,000. DLD Asset Management LP purchased a new position in IperionX in the 1st quarter worth $260,000. Finally, Corigliano Investment Advisers LLC bought a new stake in IperionX in the fourth quarter worth $362,000. 2.76% of the stock is currently owned by hedge funds and other institutional investors.

IperionX Company Profile

IperionX Limited (NASDAQ: IPX) is a materials technology company focused on developing a U.S.-based, lower-carbon titanium supply chain. The company is working to produce titanium metal, powder and other titanium products for aerospace, defense, automotive, medical and other advanced manufacturing applications.

IperionX is developing its Titan Project in Tennessee, which is designed to supply titanium minerals and support domestic production of titanium products. The project is intended to integrate the processing of titanium mineral resources with downstream manufacturing, reducing reliance on overseas sources of titanium.

The company is also advancing proprietary processing technologies, including its Hydrogen Assisted Metallothermic Reduction process, which is designed to produce titanium metal and powder with lower energy requirements than conventional methods.